Biologic Drugs With Mechanism of Action: Interleukin-23 Antagonists
Biologic Drugs With Mechanism of Action: Interleukin-23 Antagonists
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | ⤷ Start Trial | ⤷ Start Trial |
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | 10,065,007 | ⤷ Start Trial |
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | 10,099,039 | ⤷ Start Trial |
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | 10,155,018 | ⤷ Start Trial |
| Janssen Biotech, Inc. | STELARA | ustekinumab | Injection | 125261 | 2009-09-25 | 10,232,014 | ⤷ Start Trial |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |
